How Until is Engineering Away Time in Organ Transplants | Laura Deming

Laura Deming, co-founder and CEO of Until, discusses the frontier of reversible cryopreservation, beginning with human organs and progressing to whole-body hibernation. The primary goal is to create a new form of critical care, providing an "ambulance for the future" by hibernating individuals until a cure for their disease becomes available. Deming highlights the stochastic nature of ice formation, emphasizing the importance of avoiding ice formation during cryopreservation. She notes that the ability to trade off engineering and biological challenges makes the problem interesting, as better engineering can ease biological difficulties. Until aims to transform organ transplantation by making time not a variable, allowing for better matching and reducing the constricting experience for transplant patients.